Cara Therapeutics GAAP EPS of -$0.59 misses by $0.23, revenue of $3M misses by $6.13M Published 04 Mar 2024 Full Article
Zevra Therapeutics GAAP EPS of -$1.30 misses by $0.12, revenue of $27.46M beats by $1.48M SeekingAlpha 28 Mar 2024
Oncternal Therapeutics GAAP EPS of -$3.11 misses by $0.03, revenue of $0.3M beats by $0.16M SeekingAlpha 07 Mar 2024